These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 147185)

  • 1. Individual variability and correlation of the in vitro tests in tolerant rats.
    Holán V; Chutná J; Hasek M
    Folia Biol (Praha); 1978; 24(1):16-24. PubMed ID: 147185
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of neonatally and adoptively induced transplantation tolerance in mice.
    Hasek M; Holán V; Chutná J
    Folia Biol (Praha); 1980; 26(3):167-75. PubMed ID: 6448173
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Suppression of allosensitization in vitro by cells from tolerant rats.
    Holán V; Hasek M; Chutná J
    Folia Biol (Praha); 1978; 24(2):95-103. PubMed ID: 149029
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mixed leukocyte culture reactivity in operationally tolerant rats: Relationship of lymphocyte-mediated reactivity and serum-blocking activity.
    Bernstein ID; Hamilton BL; Wright PW; Burstein R; Hellstrom KE
    J Immunol; 1975 Jan; 114(1 Pt 2):320-5. PubMed ID: 123257
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Suppressor cells in transplantation tolerance. I. Analysis of the suppressor status of neonatally and adoptively tolerized rats.
    Dorsch S; Roser B
    Transplantation; 1982 May; 33(5):518-24. PubMed ID: 6211808
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanisms maintaining antibody-induced enhancement of allografts. II. Mediation of specific suppression by short lived CD4+ T cells.
    Pearce NW; Spinelli A; Gurley KE; Dorsch SE; Hall BM
    J Immunol; 1989 Jul; 143(2):499-506. PubMed ID: 2472441
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Two phenotypically distinct populations of T cells have suppressor capabilities simultaneously in the maintenance phase of immunologic enhancement.
    Padberg WM; Lord RH; Kupiec-Weglinski JW; Williams JM; Di Stefano R; Thornburg LE; Araneda D; Strom TB; Tilney NL
    J Immunol; 1987 Sep; 139(6):1751-7. PubMed ID: 2957435
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interactions between T lymphocyte subsets supported by interleukin 2-rich lymphokines produce acute rejection of vascularized cardiac allografts in T cell deprived rats.
    Heidecke CD; Kupiec-Weglinski JW; Lear PA; Abbud-Filho M; Araujo JL; Araneda D; Strom TB; Tilney NL
    J Immunol; 1984 Aug; 133(2):582-8. PubMed ID: 6234351
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Donor-specific renal, but not cardiac, allograft tolerance promotes engraftment of the normally rejected rat skin graft.
    Margenthaler JA; Yu S; Otomo N; Lehmann M; Flye MW
    Transpl Int; 2003 Oct; 16(10):713-20. PubMed ID: 12827227
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enhancement of passive antilisterial immunity and change of Lyt phenotype following in vitro stimulation of murine lymphoid cells from immune donors.
    Barry RA; Hinrichs DJ
    Clin Invest Med; 1984; 7(4):303-9. PubMed ID: 6442653
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Allochimeric therapy induces unique regulatory T cells that mitigate chronic rejection.
    Semiletova NV; Shen XD; Slomowitz SJ; Baibakov B; Feldman DM; Busuttil RW; Kupiec-Weglinski JW; Ghobrial RM
    Transplant Proc; 2005; 37(1):35-6. PubMed ID: 15808538
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro reactivity of lymphoid cells from tolerant mice.
    Beverley PC; Brent L; Brooks C; Medawar PB; Simpson E
    Transplant Proc; 1973 Mar; 5(1):679-84. PubMed ID: 4266673
    [No Abstract]   [Full Text] [Related]  

  • 13. Testing immunological responses to experimental allografts.
    Hamburger J; Debray-Sachs M; Dimitriu A; Dy M; Caraux J
    Transplant Proc; 1974 Dec; 6(4 Suppl 1):85-91. PubMed ID: 4280168
    [No Abstract]   [Full Text] [Related]  

  • 14. Effect of selective T cell depletion of host and/or donor bone marrow on lymphopoietic repopulation, tolerance, and graft-vs-host disease in mixed allogeneic chimeras (B10 + B10.D2----B10).
    Ildstad ST; Wren SM; Bluestone JA; Barbieri SA; Stephany D; Sachs DH
    J Immunol; 1986 Jan; 136(1):28-33. PubMed ID: 2933464
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The persistence of regulatory cells developing after rat spontaneous liver acceptance.
    Asakura H; Takayashiki T; Ku G; Flye MW
    Surgery; 2005 Aug; 138(2):329-34. PubMed ID: 16153444
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Functional clonal deletion and suppression as complementary mechanisms operative in adult hapten-induced cytotoxic T cell tolerance.
    Good MF; Nossal GJ
    J Immunol; 1983 Dec; 131(6):2662-9. PubMed ID: 6227660
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Heterogeneity of the tolerant state in rats with long established skin grafts.
    Smith RN; Howard JC
    J Immunol; 1980 Nov; 125(5):2289-94. PubMed ID: 6448895
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transfusion induces blood donor-specific suppressor cells.
    Quigley RL; Wood KJ; Morris PJ
    J Immunol; 1989 Jan; 142(2):463-70. PubMed ID: 2521347
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cyclosporine-induced tolerance in experimental organ transplantation. Evidence of diminished donor-specific cytotoxicity relative to donor-specific proliferative response.
    Norin AJ; Kamholz SL; Pinsker KL; Emeson EE; Veith FJ
    J Immunol; 1987 Jul; 139(2):332-7. PubMed ID: 2955037
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The MLC response of lymphocytes from mice neonatally primed and tolerating skin allografts.
    Cukrová V; Holán V; Rychlíková M
    Folia Biol (Praha); 1981; 27(5):308-17. PubMed ID: 6457758
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.